133 related articles for article (PubMed ID: 30297302)
1. Growth of diabetes drug expenditure decomposed-A nationwide analysis.
Soppi A; Heino P; Kurko T; Maljanen T; Saastamoinen L; Aaltonen K
Health Policy; 2018 Dec; 122(12):1326-1332. PubMed ID: 30297302
[TBL] [Abstract][Full Text] [Related]
2. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
Rathmann W; Haastert B; Icks A; Giani G
Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
[TBL] [Abstract][Full Text] [Related]
3. Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.
Luo J; Avorn J; Kesselheim AS
JAMA Intern Med; 2015 Oct; 175(10):1681-6. PubMed ID: 26301721
[TBL] [Abstract][Full Text] [Related]
4. Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?
McEwen LN; Casagrande SS; Kuo S; Herman WH
Curr Diab Rep; 2017 Sep; 17(9):71. PubMed ID: 28741264
[TBL] [Abstract][Full Text] [Related]
5. Drug spending in Canada: recent trends and causes.
Morgan S
Med Care; 2004 Jul; 42(7):635-42. PubMed ID: 15213487
[TBL] [Abstract][Full Text] [Related]
6. Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan.
Morgan SG
Health Serv Res; 2002 Oct; 37(5):1243-66. PubMed ID: 12479495
[TBL] [Abstract][Full Text] [Related]
7. Trends in antidiabetic drug utilization and expenditure in Denmark: A 22-year nationwide study.
Bang C; Mortensen MB; Lauridsen KG; Bruun JM
Diabetes Obes Metab; 2020 Feb; 22(2):167-172. PubMed ID: 31486269
[TBL] [Abstract][Full Text] [Related]
8. Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand.
Limwattananon C; Waleekhachonloet O
PLoS One; 2019; 14(2):e0211759. PubMed ID: 30785916
[TBL] [Abstract][Full Text] [Related]
9. International prices and availability of pharmaceuticals in 2005.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
[TBL] [Abstract][Full Text] [Related]
10. The power of r - pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?
Petrou P
Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):289-300. PubMed ID: 24580120
[TBL] [Abstract][Full Text] [Related]
11. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
Cheng N; Banerjee T; Qian J; Hansen RA
J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
[TBL] [Abstract][Full Text] [Related]
12. Trends in antidiabetic drug use and expenditure in public hospitals in Northwest China, 2012-21: a case study of Gansu Province.
Cao W; Feng H; Yang Y; Wang L; Wang X; Ma Y; Zhao D; Hu X
BMC Health Serv Res; 2024 Apr; 24(1):415. PubMed ID: 38570849
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
[TBL] [Abstract][Full Text] [Related]
14. Biosimilar Insulin and Costs: What Can We Expect?
Heinemann L
J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
[TBL] [Abstract][Full Text] [Related]
15. Pharmacy and neighborhood-level variation in cash price of diabetes medications in the United States.
Warraich HJ; Siddiqi HK; Li DG; van Meijgaard J; Vaduganathan M
PLoS One; 2023; 18(12):e0294164. PubMed ID: 38060500
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Price-Volume Agreement Program in South Korea.
Han E; Park SY; Lee EK
Health Policy; 2016 Oct; 120(10):1209-1215. PubMed ID: 27519975
[TBL] [Abstract][Full Text] [Related]
17. Diabetes drugs in England cost nearly £1bn last year.
Kmietowicz Z
BMJ; 2016 Aug; 354():i4324. PubMed ID: 27492677
[No Abstract] [Full Text] [Related]
18. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
Jünger C; Rathmann W; Giani G
Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
[TBL] [Abstract][Full Text] [Related]
19. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
20. Trends in Prescription Drug Spending Leading Up to Health Reform.
Blavin F; Waidmann T; Blumberg LJ; Roth J
Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
